Statin therapy reduces risk for diabetic retinopathy in T2DM

(HealthDay)—For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according to a study published online Jan. 10 in JAMA Ophthalmology. Eugene Yu-Chuan Kang, M.D., from the Chang Gung Memorial Hospital in Taoyuan, Taiwan, and colleagues examined the correlation between statin therapy and development of diabetic retinopathy in patients with […]

Continue reading »

Rob Delaney Has an Important Message for Bereaved Parents & Children

In January, actor-comedian Rob Delaney and his wife suffered the devastating loss of their two-year-old son, Henry. Little Henry passed away from cancer after a surgery to have a brain tumor removed. “Henry was a joy,” Delaney wrote in a February Facebook post. “He was smart, funny, and mischievous and we had so many wonderful adventures together, particularly after he’d […]

Continue reading »

FDA approves drugs for treatment of two rare blood diseases

(HealthDay)—Two drugs have been approved by the U.S. Food and Drug Administration for the treatment of rare blood diseases, the agency announced Friday. Elzonris (tagraxofusp-erzs) infusion was granted the first approval for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and children aged 2 years and older. Researchers investigated the efficacy of Elzonris in two patient cohorts […]

Continue reading »

A role for microRNAs in social behavior

The recent discovery of microRNAs as key regulators of biological processes has fueled an explosion of research activity into their function in health and disease. Researchers have now uncovered a microRNA cluster that regulates synaptic strength and is involved in the control of social behaviour in mammals. The researchers presume that their discovery may point to new therapeutic strategies for […]

Continue reading »

Research suggests path to vaccine or drug for late-onset Alzheimer’s

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults. Apolipoprotein E (ApoE) is a protein that carries fatty substances […]

Continue reading »

Researchers find the cause of and cure for brain injury associated with gut condition

Using a mouse model of necrotizing enterocolitis (NEC)—a potentially fatal condition that causes a premature infant’s gut to suddenly die—researchers at Johns Hopkins say they have uncovered the molecular causes of the condition and its associated brain injury. The discovery enabled the team to combine efforts with colleagues studying brain inflammation and to identify potential drugs that reverse the brain […]

Continue reading »

Major data release set for early 2019 as recruitment wraps up for nation’s largest adolescent brain study

Research teams all across the globe are eagerly awaiting a major release of data from the largest study ever attempted on the adolescent brain. FIU is one of 21 sites studying nearly 11,874 participants collectively, including 2,100 twins or triplets. Researchers will follow the children, currently between the ages of 9 and 10, through young adulthood. Recruitment for participants wrapped […]

Continue reading »
1 16 17 18 19 20 42